Category | Experimental (n = 39,355) | Control (n = 21,815) | Study Sample (n = 61,170) | Overall (n = 870,255) |
---|---|---|---|---|
Age (mean ± SD)a | 32.13 ± 11.18 | 32.60 ± 11.20 | 32.3 ± 11.19 | 33.7 ± 11.6 |
 13–17 years | 1151 (2.9%) | 621 (2.8%) | 1772 (2.9%) | 27,452 (4%) |
 18–24 years | 9848 (25.0%) | 5096 (23.4%) | 14,944 (24.4%) | 178,439 (24%) |
 25–34 years | 15,102 (38.4%) | 8278 (37.9%) | 23,380 (38.2%) | 241,746 (32%) |
 35–44 years | 7332 (18.6%) | 4374 (20.1%) | 11,706 (19.1%) | 140,785 (19%) |
 45–54 years | 3854 (9.8%) | 2267 (10.4%) | 6121 (10%) | 97,143 (13%) |
 55–64 years | 1729 (4.4%) | 957 (4.4%) | 2677 (4.4%) | 52,023 (7%) |
 65+ years | 348 (0.9%) | 222 (1.0%) | 570 (0.9%) | 17,563 (2%) |
Genderb | ||||
 Female | 25,133 (63.9%) | 13,737 (63.0%) | 38,870 (63.5%) | 548,305 (59%) |
 Male | 14,222 (36.1%) | 8.078 (37.0%) | 22,300 (36.5%) | 370,126 (40%) |
Provincec | ||||
 BC | 7714 (19.6%) | 3940 (18.1%) | 11,654 (19.1%) | 215,654 (24.8%) |
 NL | 1116 (2.8%) | 492 (2.3%) | 1608 (2.6%) | 40,314 (4.6%) |
 ON | 30,525 (77.6%) | 17,383 (79.7%) | 47,908 (78.3%) | 614,287 (70.6%) |
Baseline Daily Step Countd | 6074 ± 3358 | 6076 ± 3333 | 6075 ± 3349 | 5560 ± 2726e |
Pre-Intervention (valid weeks) | 11.16 ± 1.7 | 10.81 ± 2.0 | 11.03 ± 1.8 | n/a |
Intervention (valid weeks) | 11.47 ± 1.4 | 10.86 ± 2.1 | 11.25 ± 1.7 | n/a |